ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $54,000 | +134.8% | 9,077 | +4.1% | 0.00% | – |
| Q2 2019 | $23,000 | -11.5% | 8,721 | 0.0% | 0.00% | – |
| Q1 2019 | $26,000 | +100.0% | 8,721 | 0.0% | 0.00% | – |
| Q4 2018 | $13,000 | -59.4% | 8,721 | 0.0% | 0.00% | – |
| Q3 2018 | $32,000 | +28.0% | 8,721 | 0.0% | 0.00% | – |
| Q2 2018 | $25,000 | -21.9% | 8,721 | 0.0% | 0.00% | – |
| Q1 2018 | $32,000 | +28.0% | 8,721 | 0.0% | 0.00% | – |
| Q4 2017 | $25,000 | -34.2% | 8,721 | 0.0% | 0.00% | – |
| Q3 2017 | $38,000 | -5.0% | 8,721 | 0.0% | 0.00% | – |
| Q2 2017 | $40,000 | +8.1% | 8,721 | 0.0% | 0.00% | – |
| Q1 2017 | $37,000 | +2.8% | 8,721 | 0.0% | 0.00% | – |
| Q4 2016 | $36,000 | -74.3% | 8,721 | -50.0% | 0.00% | – |
| Q3 2016 | $140,000 | +105.9% | 17,442 | +100.0% | 0.00% | – |
| Q2 2016 | $68,000 | +1.5% | 8,721 | 0.0% | 0.00% | – |
| Q1 2016 | $67,000 | -28.7% | 8,721 | 0.0% | 0.00% | – |
| Q4 2015 | $94,000 | +56.7% | 8,721 | 0.0% | 0.00% | – |
| Q3 2015 | $60,000 | -22.1% | 8,721 | 0.0% | 0.00% | – |
| Q2 2015 | $77,000 | -10.5% | 8,721 | 0.0% | 0.00% | – |
| Q1 2015 | $86,000 | -19.6% | 8,721 | 0.0% | 0.00% | – |
| Q4 2014 | $107,000 | – | 8,721 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |